Search Results
Jun 07, 2026, 08:40 ET CERAVE 舉辦首屆全球 CERAWARDS 大賽，表揚來自 22 個國家、超過 100 位得獎內容創作者
圓滿落幕，創作者同聚一晚，共同頌揚持續引領網上護膚文化的才華、創意及原創精神。 頒獎典禮由演員兼喜劇演員 Meg Stalter 主持，國際評審團陣容包括演員 Bailee Madison、美國皮膚科委員會認證皮膚科醫生兼創作者 Andrew Park 博士，以及 CeraVe 全球醫療事務與傳訊高級副總裁 Gene Colón。典禮為首屆全球 CerAwards 大賽得主加冕，迎接其加入 CeraVe 全球創作者聯盟 Ceramide Squad，頌揚社群中的超凡創意，並讚譽旅程中誕生的精彩作品。科學為根基， 創作者傳頌。CeraVe 自 2005
More news about: CeraVe
Jun 06, 2026, 22:42 ET CERAVE ЧЕСТВУЕТ БОЛЕЕ 100 АВТОРОВ КОНТЕНТА ИЗ 22 СТРАН В РАМКАХ ПЕРВОЙ В ИСТОРИИ ЦЕРЕМОНИИ ВРУЧЕНИЯ ПРЕМИИ GLOBAL CERAWARDS
жюри вошли актриса Бейли Мэдисон (Bailee Madison), сертифицированный дерматолог и создатель контента д-р Эндрю Парк (Andrew Park), а также Джин Колон (Gene Colón), старший вице-президент CeraVe по медицинским вопросам и коммуникациям на глобальном уровне.В ходе церемонии были объявлены
More news about: CeraVe
Jun 06, 2026, 22:36 ET CERAVE RAYAKAN LEBIH DARI 100 KREATOR KONTEN PERAIH PENGHARGAAN DARI 22 NEGARA DI AJANG CERAWARDS GLOBAL PERDANA
Meg Stalter ini menampilkan dewan juri global seperti aktris Bailee Madison; Ahli Demartologi Bersertifikasi dan pembuat konten, Dr. Andrew Park; dan Gene Colón, Wakil Presiden Senior Global Bidang Medical Affairs & Communications di CeraVe.Acara penghargaan ini mengumumkan nama
More news about: CeraVe
Jun 06, 2026, 22:30 ET CERAVE TÔN VINH HƠN 100 NHÀ SÁNG TẠO NỘI DUNG TỪNG GIÀNH GIẢI THƯỞNG TỪ 22 QUỐC GIA TRONG CUỘC THI CERAWARDS TOÀN CẦU ĐẦU TIÊN
trình, với ban giám khảo toàn cầu bao gồm nữ diễn viên Bailee Madison, Bác Sĩ Da Liễu Được Hội Đồng Chứng Nhận kiêm nhà sáng tạo Bác Sĩ Andrew Park, và Gene Colón - Phó Chủ Tịch Cấp Cao Toàn Cầu phụ trách Sự Vụ Y Tế và Truyền Thông tại CeraVe.Buổi lễ đã vinh danh những người chiến thắng CerAwards
More news about: CeraVe
Jun 06, 2026, 13:13 ET CERAVE NA PRVNÍCH CELOSVĚTOVÝCH CERAWARDS PŘIVÍTALO VÍCE NEŽ 100 OCENĚNÝCH TVŮRCŮ OBSAHU Z 22 ZEMÍ
provázela herečka a komička Meg Stalter. V porotě zasedli mimo jiné herečka Bailee Madison, certifikovaný dermatolog a tvůrce obsahu Dr. Andrew Park a Gene Colón, globální senior viceprezident pro zdravotnické záležitosti a komunikaci ve společnosti CeraVe.Během večera byli vyhlášeni první vítězové
More news about: CeraVe
Jun 05, 2026, 20:30 ET Ractigen Therapeutics Announces ADA 2026 Late-Breaking Presentation Highlighting saRNA as a New Frontier in Obesity Control
validated platform technology developed by Dr. Long-Cheng Li and his team. It utilizes small activating RNAs (saRNAs) to target gene regulatory domains, robustly activating endogenous gene expression and restoring therapeutic protein levels. This innovative technology holds vast potential for developing disease-modifying
More news about: Ractigen Therapeutics
Jun 05, 2026, 12:21 ET O CERAVE CELEBRA MAIS DE 100 CRIADORES DE CONTEÚDO PREMIADOS DE 22 PAÍSES PELOS PRIMEIROS CERAWARDS GLOBAIS
cerimônia contou com um painel de jurados global, incluindo a atriz Bailee Madison, dermatologista e criador certificado pelo conselho, Dr. Andrew Park, e Gene Colón - vice-presidente sênior global de assuntos médicos e comunicações da CeraVe.A cerimônia coroou os vencedores inaugurais do Global CerAwards,
More news about: CeraVe
Jun 05, 2026, 12:04 ET CeraVe premia a más de 100 creadores de contenido galardonados de 22 países en los CerAwards
Stalter, la ceremonia contó con un jurado internacional compuesto por la actriz Bailee Madison, el Dr. Andrew Park, dermatólogo certificado y creador, y Gene Colón, vicepresidente sénior global de Asuntos Médicos y Comunicaciones de CeraVe.La ceremonia coronó a los primeros ganadores de
More news about: CeraVe
Jun 05, 2026, 11:35 ET CERAVE FEIERT ÜBER 100 PREISGEKRÖNTE CONTENT-SCHÖPFER AUS 22 LÄNDERN BEI DEN ERSTEN GLOBALEN CERAWARDS
Zeremonie wurde von einer internationalen Jury begleitet, zu der die Schauspielerin Bailee Madison, der Dermatologe und Erfinder Dr. Andrew Park und Gene Colón - Global SVP, Medical Affairs & Communications bei CeraVe - gehörten.Die Zeremonie krönte die ersten Gewinner der Global CerAwards
More news about: CeraVe
Jun 05, 2026, 11:26 ET CERAVE RÉCOMPENSE PLUS DE 100 CRÉATEURS DE CONTENU PRIMÉS DANS 22 PAYS POUR LA PREMIÈRE ÉDITION MONDIALE DES CERAWARDS
Stalter, la cérémonie a réuni un jury international composé de l'actrice Bailee Madison, du Dr Andrew Park, dermatologue certifié et créateur, et de Gene Colón, SVP mondial des affaires médicales et de la communication chez CeraVe.La cérémonie a couronné les premiers lauréats des Global CerAwards,
More news about: CeraVe
Jun 05, 2026, 11:20 ET CERAVE CELEBRA A MÁS DE 100 CREADORES DE CONTENIDO GALARDONADOS DE 22 PAÍSES PARA LOS PRIMEROS CERAWARDS GLOBALES
contó con un panel de jueces global que incluyó a la actriz Bailee Madison, el dermatólogo y creador certificado por la junta, el Dr. Andrew Park, y Gene Colón, vicepresidente senior global de Asuntos Médicos y Comunicaciones en CeraVe.La ceremonia coronó a los ganadores inaugurales de los Global
More news about: CeraVe
Jun 05, 2026, 10:00 ET Eratrectinib, the next-generation TRK inhibitor independently developed by Vcare PharmaTech, has received marketing approval
2026 /PRNewswire/ -- NTRK gene fusions have been identified as oncogenic drivers in adult and pediatric patients with pan-solid tumors. A fusion gene is typically formed by the combination of an NTRK gene containing a kinase domain and its fusion partner gene. To date, more than 229 fusion partner
More news about: Vcare PharmaTech
Jun 05, 2026, 08:45 ET Morphy's To Host Live Auction Of Outstanding Western Art And Antiques On June 20, During The 36th Annual Old West Show In Santa Fe
circa 1937. The silversmith responsible for the fine decorations was Robert Schaezlein, who operated a shop out of San Francisco, and the tooling was by Gene Sisco. The saddle is in pristine condition, having been mounted on a horse only twice since its inception in 1937. It is accompanied by an original
More news about: Morphy Auctions
Jun 05, 2026, 08:02 ET CERAVE CELEBRATES OVER 100 AWARD-WINNING CONTENT CREATORS FROM 22 COUNTRIES FOR THE FIRST EVER GLOBAL CERAWARDS
Stalter, the ceremony featured a global judging panel including actress Bailee Madison, Board-Certified Dermatologist and creator Dr. Andrew Park, and Gene Colón - Global SVP, Medical Affairs & Communications at CeraVe.The ceremony crowned the inaugural Global CerAwards winners, inducting them
More news about: CeraVe
Jun 05, 2026, 08:02 ET CERAVE CELEBRATES OVER 100 AWARD-WINNING CONTENT CREATORS FROM 22 COUNTRIES FOR THE FIRST EVER GLOBAL CERAWARDS
Stalter, the ceremony featured a global judging panel including actress Bailee Madison, Board-Certified Dermatologist and creator Dr. Andrew Park, and Gene Colón - Global SVP, Medical Affairs & Communications at CeraVe.The ceremony crowned the inaugural Global CerAwards winners, inducting them
More news about: CeraVe
Jun 05, 2026, 08:00 ET Kihealth Announces Launch of Beta Intercept™, Advancing Real-Time Detection of Diabetes
assay utilizes an advanced droplet digital PCR (ddPCR) platform that simultaneously evaluates three distinct methylation sites within the insulin (INS) gene, significantly improving assay specificity, signal consistency, and analytical robustness compared with prior versions. The new product also incorporates
More news about: Kihealth
Jun 04, 2026, 17:06 ET Lundbeck presents positive Phase IIb data for bocunebart (Lu AG09222; anti-PACAP mAb) in migraine prevention at the AHS congress
Bocunebart is designed to bind to and inhibit PACAP, a neuropeptide implicated in migraine pathophysiology through pathways distinct from calcitonin gene-related peptide (CGRP). This differentiated mechanism positions bocunebart as a potential alternative treatment option for patients who do not achieve
More news about: H. Lundbeck A/S
Jun 04, 2026, 17:04 ET Lundbeck presents positive Phase IIb data for bocunebart (Lu AG09222; anti-PACAP mAb) in migraine prevention at the AHS congress
Bocunebart is designed to bind to and inhibit PACAP, a neuropeptide implicated in migraine pathophysiology through pathways distinct from calcitonin gene-related peptide (CGRP). This differentiated mechanism positions bocunebart as a potential alternative treatment option for patients who do not achieve
More news about: H. Lundbeck A/S
Jun 04, 2026, 16:20 ET Pacira BioSciences Reminds Stockholders to Vote the BLUE Proxy Card "FOR" the Election of the Company's Highly Qualified Nominees Ahead of its Annual Meeting
assets for musculoskeletal pain and adjacencies, its most advanced product candidate, PCRX-201 (enekinragene inzadenovec), a novel locally administered gene therapy, is in Phase 2 clinical development for osteoarthritis of the knee. To learn more about Pacira, visit
More news about: Pacira BioSciences, Inc.
Jun 04, 2026, 12:01 ET ChoiceOne Bank Awards Scholarships to 19 High School Seniors
Fulton – Fenton Senior High SchoolAneko Nichol – Fraser High SchoolSimon Tunney – Fremont High SchoolMegan Mangalathet – Gene L. Klida Utica Academy for International StudiesLilly Goss – Kearsley High SchoolGavin Wandrie – Lapeer High SchoolMadelyn
More news about: ChoiceOne Bank
Jun 04, 2026, 10:30 ET Made Scientific and Pluristyx Launch Integrated iPSC Development & Manufacturing Partnership to Advance Next-Generation iPSC-derived Cell Therapies
including induced natural killer (iNK) cells and induced mesenchymal stem cells (iMSCs), into Made Scientific's end-to-end CDMO offering for global cell and gene therapy innovators.
More news about: Made Scientific, Inc.
Jun 04, 2026, 09:00 ET Adventure Awaits: Go Off the Grid with NAVC at VMX 2027
"We live in a busy, noisy world where finding time to disconnect is almost impossible," said Gene O'Neill,
More news about: North American Veterinary Community (NAVC)
Jun 04, 2026, 07:00 ET Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
therapies to treat chronic, debilitating lung diseases. The Company's early-stage programs encompass a wide range of technologies and modalities, including gene therapy, AI-driven protein engineering, RNA end-joining, and synthetic rescue.Headquartered in Bridgewater, New Jersey, Insmed has offices and
More news about: Insmed Incorporated
Jun 04, 2026, 07:00 ET HotSpot Therapeutics Presents Preclinical Data from Small Molecule IRF5 Inhibitor Program at EULAR 2026
inhibitors demonstrated dose-dependent inhibition of cytokines and mRNA response, as well as dose-dependent down-regulation of interferon and IRF5-driven gene signatures, confirming pathway-level modulation in this model.In a cynomolgus monkey model, HotSpot's IRF5 inhibitors demonstrated complete
More news about: HotSpot Therapeutics
Jun 03, 2026, 23:36 ET MEDIPOST Secures FDA Agreement on Single Pivotal Phase 3 Study with Confirmatory Evidence BLA Filing Strategy for CARTISTEM® in the U.S.
integrated capabilities spanning across discovery research and clinical development of allogeneic cell therapy assets, cord blood banking, and cell and gene therapy contract development and manufacturing (CDMO) business portfolios. MEDIPOST successfully commercialized the world's first regulatory-approved
More news about: MEDIPOST